Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
C Allerson, B Bhat, EE Swayze, TP Prakash - US Patent 7,696,345, 2010 - Google Patents
Compositions comprising first and second oligomers are pro vided wherein at least a portion
of the first oligomer is capable of hybridizing with at least a portion of the second oligomer, at …
of the first oligomer is capable of hybridizing with at least a portion of the second oligomer, at …
Rna interference mediating small rna molecules
T Tuschl, S Elbashir, W Lendeckel, M Wilm… - US Patent App. 10 …, 2004 - Google Patents
Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene
Silencing in many organisms by a process known as RNA interference (RNAi). Using a …
Silencing in many organisms by a process known as RNA interference (RNAi). Using a …
RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNA
K Fosnaugh, J McSwiggen - US Patent App. 10/224,005, 2003 - Google Patents
Correspondence Address: MCDONNELL BOEHNEN HULBERT &(57) ABSTRACT
BERGHOFF The present invention concerns methods and reagents useful 300 SOUTH …
BERGHOFF The present invention concerns methods and reagents useful 300 SOUTH …
RNA sequence-specific mediators of RNA interference
The present invention relates to a Drosophila in vitro system which was used to demonstrate
that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore …
that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore …
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
J McSwiggen, L Beigelman - US Patent 8,202,979, 2012 - Google Patents
2004-09-27 Assigned to SIRNA THERAPEUTICS, INC. reassignment SIRNA
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
4'-thionucleosides and oligomeric compounds
B Bhat, P Dande, T Prakash, C Allerson… - US Patent App. 10 …, 2005 - Google Patents
The present invention provides modified oligomeric com pounds and compositions of
oligomeric compounds for use in the RNA interference pathway of gene modulation. The …
oligomeric compounds for use in the RNA interference pathway of gene modulation. The …
Interfering RNA molecules
K Giese, J Kaufmann, A Klippel-Giese - US Patent 7,452,987, 2008 - Google Patents
The present invention is related to a ribonucleic acid com prising a double stranded
structure whereby the double Stranded structure comprises a first strand and a second …
structure whereby the double Stranded structure comprises a first strand and a second …
RNA sequence-specific mediators of RNA interference
The present invention relates to a Drosophila in vitro System which was used to demonstrate
that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Further more …
that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Further more …
Conjugates and compositions for cellular delivery
C Vargeese, P Haeberli, W Wang, T Chen - US Patent 7,491,805, 2009 - Google Patents
0* CC (CC ([12*]) C) N ([8*]) C (= O) CCN ([3*]) C (= O) CCC (C) N ([5*]) C (= O) C1= CC= C
(N ([6*]) CC2= NC3= C (N= C2) N= C (C) NC3= O) C= C1 Chemical compound* CC (CC …
(N ([6*]) CC2= NC3= C (N= C2) N= C (C) NC3= O) C= C1 Chemical compound* CC (CC …
RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
D Morrissey, J McSwiggen… - US Patent App. 10 …, 2003 - Google Patents
The present invention concerns methods and reagents useful in modulating hepatitis B virus
(HBV) gene expression in a variety of applications, including use in therapeutic, diag nostic …
(HBV) gene expression in a variety of applications, including use in therapeutic, diag nostic …